✦ LIBER ✦
Tissue factor pathway inhibitor (TFPI) in IDDM patients with and without micro- and/or macrovascular complications: P.B. Leurs, R.v. Oerle, K. Hamulyak, B.H.R. Wolffenbuttel. Department of Internal Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, Netherlands
✍ Scribed by Leurs, P
- Book ID
- 116121224
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 111 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0300-2977
No coin nor oath required. For personal study only.